Program Schedule

143
HIV Clinical State-of-the-Art

Friday, October 10, 2014: 2:00 PM-3:30 PM
Room: The Pennsylvania Convention Center: 103-ABC

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • outline current antiretroviral therapy recommendations, including what to start and frequency of laboratory monitoring
  • summarize the latest recommendations and challenges for screening, detecting and managing sexually transmitted diseases
  • describe changes to guidelines for HIV primary care and preventive medicine, including age and gender appropriate recommendation

Target Audience: Public health practitioners, Pharmacists, Members-in-training, Infectious diseases physicians, HIV specialists, HIV clinicians, Fellows, Clinicians

Tracks: HIV-STD-TB

Moderator:  Rochelle Walensky, MD, MPH, FIDSA, Massachusetts General Hospital

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE

ACPE Number: 0221-9999-14-128-L02-P

Disclosures:

R. Walensky, None

R. M. Gulick, None

J. Marrazzo, Cepheid: Grant Investigator, Research grant

J. Aberg, Merck: Scientific Advisor, Consulting fee
Janssen: Scientific Advisor, Consulting fee
AbbVie: Scientific Advisor, Consulting fee
Amgen: Scientific Advisor, Consulting fee

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, idweek.org. All Rights Reserved.

Follow IDWeek